A new platform for drug discovery

Professor Tuomas Knowles gained his PhD in biophysics from the University of Cambridge (UK) in 2007 and went on to work at Harvard University (MA, USA) before returning to Cambridge as a lecturer, gaining professorship in 2015. He is the founder and Chief Scientific Officer of Fluidic Analytics (Cambridge, UK), a biotech company developing next-generation protein analysis platforms that operate under native conditions in solution. Here he speaks to Future Drug Discovery Editor Jennifer Straiton about Fluidic Analytics' new platform Fluidity One-W, discussing how it works and what benefit it can bring to the field of drug discovery.